T2 Biosystems Inc.

10/07/2024 | Press release | Distributed by Public on 10/07/2024 07:17

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA Cleared Direct From Blood Diagnostics for Rapid Detection of Sepsis Causing Pathogens

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.